| 1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| 2. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 3. |
Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol, 2011, 12(7): 681-692.
|
| 4. |
Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer. Lancet, 2016, 388(10060): 2654-2664.
|
| 5. |
Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet, 2015, 385(9972): 977-1010.
|
| 6. |
Ren G, Cai R, Zhang WJ, et al. Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol, 2013, 19(20): 3096-3107.
|
| 7. |
Saad F, Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol, 2012, 8(3): 321-331.
|
| 8. |
Massagué J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature, 2016, 529(7586): 298-306.
|
| 9. |
Pantel K, Speicher MR. The biology of circulating tumor cells. Oncogene, 2016, 35(10): 1216-1224.
|
| 10. |
Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett, 2007, 253(2): 180-204.
|
| 11. |
Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods, 2010, 50(4): 289-297.
|
| 12. |
Allard WJ, Matera J, Miller MC, et a1. Tumor cells circulate in theperi pheral blood of all major carcinom as but not in healthy subjects orpatients with nonmalignant diseases. Clin Cancer Res, 2004, 10(20): 6897-6904.
|
| 13. |
中華人民共和國衛生部. 胃癌診斷標準(WS316-2010). 北京: 中國標準出版社, 2010.
|
| 14. |
廖專, 孫濤, 吳浩, 等. 中國早期胃癌篩查及內鏡診治共識意見(2014年4月·長沙). 胃腸病學, 2014, 34(7): 408-427.
|
| 15. |
Yang C, Zou K, Yuan Z, et al. Prognostic value of circulating tumor cells detected with the CellSearch system in patients with gastric cancer: evidence from a meta-analysis. Onco Targets Ther, 2018, 11: 1013-1023.
|
| 16. |
Yang C, Zhang N, Wang S, et al. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer. J Transl Med, 2018, 16(1): 139.
|
| 17. |
Okabe H, Tsunoda S, Hosogi H, et al. Circulating tumor cells as an independent predictor of survival in advanced gastric cancer. Ann Surg Oncol, 2015, 22(12): 3954-3961.
|
| 18. |
Zheng L, Zou K, Yang C, et al. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients. Clin Transl Oncol, 2017, 19(9): 1125-1132.
|
| 19. |
韓鴻彬, 李朝輝, 劉帥鋒, 等. 胃癌患者外周血循環腫瘤細胞檢測及其臨床意義. 中國普外基礎與臨床雜志, 2015, 22(7): 840-843.
|
| 20. |
曹中正, 丁連安, 牛冬光, 等. 胃癌外周血循環腫瘤細胞水平及其臨床意義. 臨床腫瘤學雜志, 2014, 19(6): 539-542.
|
| 21. |
Kubisch I, de Albuquerque A, Schuppan D, et al. Prognostic role of a multimarker analysis of circulating tumor cells in advanced gastric and gastroesophageal adenocarcinomas. Oncology, 2015, 89(5): 294-303.
|